Significant response to pralsetinib in a medullary thyroid cancer harboring double RET variants of unknown significance

Detalles Bibliográficos
Autores principales: Hescot, Ségolène, Masliah-Planchon, Julien, du Rusquec, Pauline, Dupain, Célia, Kamal, Maud, Servois, Vincent, Bieche, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578058/
https://www.ncbi.nlm.nih.gov/pubmed/36053791
http://dx.doi.org/10.1530/ETJ-22-0044
_version_ 1784811892987920384
author Hescot, Ségolène
Masliah-Planchon, Julien
du Rusquec, Pauline
Dupain, Célia
Kamal, Maud
Servois, Vincent
Bieche, Ivan
author_facet Hescot, Ségolène
Masliah-Planchon, Julien
du Rusquec, Pauline
Dupain, Célia
Kamal, Maud
Servois, Vincent
Bieche, Ivan
author_sort Hescot, Ségolène
collection PubMed
description
format Online
Article
Text
id pubmed-9578058
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-95780582022-10-18 Significant response to pralsetinib in a medullary thyroid cancer harboring double RET variants of unknown significance Hescot, Ségolène Masliah-Planchon, Julien du Rusquec, Pauline Dupain, Célia Kamal, Maud Servois, Vincent Bieche, Ivan Eur Thyroid J Case Report Bioscientifica Ltd 2022-09-27 /pmc/articles/PMC9578058/ /pubmed/36053791 http://dx.doi.org/10.1530/ETJ-22-0044 Text en © The authors https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License. (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Case Report
Hescot, Ségolène
Masliah-Planchon, Julien
du Rusquec, Pauline
Dupain, Célia
Kamal, Maud
Servois, Vincent
Bieche, Ivan
Significant response to pralsetinib in a medullary thyroid cancer harboring double RET variants of unknown significance
title Significant response to pralsetinib in a medullary thyroid cancer harboring double RET variants of unknown significance
title_full Significant response to pralsetinib in a medullary thyroid cancer harboring double RET variants of unknown significance
title_fullStr Significant response to pralsetinib in a medullary thyroid cancer harboring double RET variants of unknown significance
title_full_unstemmed Significant response to pralsetinib in a medullary thyroid cancer harboring double RET variants of unknown significance
title_short Significant response to pralsetinib in a medullary thyroid cancer harboring double RET variants of unknown significance
title_sort significant response to pralsetinib in a medullary thyroid cancer harboring double ret variants of unknown significance
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578058/
https://www.ncbi.nlm.nih.gov/pubmed/36053791
http://dx.doi.org/10.1530/ETJ-22-0044
work_keys_str_mv AT hescotsegolene significantresponsetopralsetinibinamedullarythyroidcancerharboringdoubleretvariantsofunknownsignificance
AT masliahplanchonjulien significantresponsetopralsetinibinamedullarythyroidcancerharboringdoubleretvariantsofunknownsignificance
AT durusquecpauline significantresponsetopralsetinibinamedullarythyroidcancerharboringdoubleretvariantsofunknownsignificance
AT dupaincelia significantresponsetopralsetinibinamedullarythyroidcancerharboringdoubleretvariantsofunknownsignificance
AT kamalmaud significantresponsetopralsetinibinamedullarythyroidcancerharboringdoubleretvariantsofunknownsignificance
AT servoisvincent significantresponsetopralsetinibinamedullarythyroidcancerharboringdoubleretvariantsofunknownsignificance
AT biecheivan significantresponsetopralsetinibinamedullarythyroidcancerharboringdoubleretvariantsofunknownsignificance

Ejemplares similares